bendamustine hydrochloride has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Colapietro, A; Cristiano, L; Delle Monache, S; Festuccia, C; Gravina, GL; Mancini, A; Marampon, F; Mehrling, T; Pompili, S; Tombolini, V; Vetuschi, A; Vitale, F | 1 |
| Chamberlain, MC; Johnston, SK | 1 |
1 trial(s) available for bendamustine hydrochloride and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Salvage therapy with single agent bendamustine for recurrent glioblastoma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Brain Neoplasms; Disease-Free Survival; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Salvage Therapy | 2011 |
1 other study(ies) available for bendamustine hydrochloride and Astrocytoma, Grade IV
| Article | Year |
|---|---|
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Benzimidazoles; Brain Neoplasms; Cell Line, Tumor; Female; Glioblastoma; Histone Deacetylase Inhibitors; Humans; Mice; Vorinostat | 2018 |